Key result
Severe COVID-19 with background risk factors warrants heightened surveillance for hypercoagulability.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May warrant thrombosis vigilance in severe COVID-19 with comorbidities; leaves open optimal screening protocols pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Moghimi et al. (2020) studied this question. Severe COVID-19 patients with background risk factors require careful evaluation of their hypercoagulability state.
Synapse has enriched 10 related papers. Consider them for comparative context: